The Nevada Athletic Commission has instituted new policies that draw the line between what drug testing results it deems “atypical” as opposed to “adverse.”
At a monthly meeting Tuesday, the NAC established new thresholds for substances previously prohibited: GW1516, dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3), clomiphene, epitrenbolone (trenbolone metabolite), and selective androgen receptor modulators (SARMS).
